Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. (EGX:RMDA)

EGX:RMDA Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	64.69	52.36	66.96	14	13.23
Short-Term Investments	189.7	260.9	361.86	468.01	469.35
Cash & Short-Term Investments	254.39	313.25	428.82	482.01	482.58
Cash Growth	-18.79%	-26.95%	-11.04%	-0.12%	-6.99%
Accounts Receivable	791.26	353.74	276.6	265.96	238.41
Other Receivables	103.43	72.16	22.6	25.2	33.11
Receivables	1,582	1,344	923.28	684.61	666.63
Inventory	751.34	303.26	348.41	259.4	305.48
Prepaid Expenses	4.29	2.21	2.83	0.99	0.91
Other Current Assets	544.65	60.33	55.14	48.64	40.98
Total Current Assets	3,137	2,023	1,758	1,476	1,497
Property, Plant & Equipment	621.52	606.05	556.98	554.99	538.16
Other Intangible Assets	552.79	589.27	457.57	389.66	214.57
Total Assets	4,311	3,218	2,773	2,420	2,249
Accounts Payable	264.36	102.41	120.25	61.53	46.93
Accrued Expenses	115.09	76.44	62.92	37.31	21.18
Short-Term Debt	1,555	1,098	910.18	842.6	823.75
Current Portion of Long-Term Debt	-	-	-	21.95	58.85
Current Portion of Leases	4.48	4.81	3.66	3.13	2.6
Current Income Taxes Payable	98.78	60.59	53.71	33.49	18.31
Other Current Liabilities	117.77	30.67	31.23	22.05	18.71
Total Current Liabilities	2,155	1,373	1,182	1,022	990.33
Long-Term Debt	-	-	-	-	29.55
Long-Term Leases	7.19	11.7	16.34	12.26	14.81
Long-Term Deferred Tax Liabilities	77.28	58.23	51.56	40.5	31.06
Total Liabilities	2,240	1,443	1,250	1,075	1,066
Common Stock	378.23	375	250	250	192.15
Additional Paid-In Capital	327.51	377.7	397.52	486.97	486.97
Retained Earnings	1,351	1,022	921.68	610.87	505.79
Treasury Stock	-26.23	-26.23	-65.93	-	-
Comprehensive Income & Other	13.31	14.21	15.31	0.28	0.28
Total Common Equity	2,044	1,763	1,519	1,348	1,185
Minority Interest	27.38	12.94	4.59	-2.62	-1.62
Shareholders' Equity	2,072	1,775	1,523	1,345	1,184
Total Liabilities & Equity	4,311	3,218	2,773	2,420	2,249
Total Debt	1,566	1,114	930.18	879.94	929.56
Net Cash (Debt)	-1,312	-801.18	-501.37	-397.93	-446.98
Net Cash Per Share	-0.87	-0.53	-0.34	-0.26	-0.29
Filing Date Shares Outstanding	1,503	1,491	1,491	1,523	1,523
Total Common Shares Outstanding	1,503	1,491	1,478	1,523	1,523
Working Capital	981.82	650.11	576.53	453.59	506.26
Book Value Per Share	1.36	1.18	1.03	0.89	0.78
Tangible Book Value	1,491	1,173	1,061	958.45	970.62
Tangible Book Value Per Share	0.99	0.79	0.72	0.63	0.64
Land	18.64	18.64	18.64	18.64	18.64
Buildings	294.77	288.43	279.17	273.34	257.23
Machinery	646.31	585.04	533.6	491.55	462.1
Construction In Progress	33.46	38.09	12.86	27.04	26.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.